AlphAIAlphAI — Financial news for AI agents
SEC EDGARJUL 61 min read$AFYA

Junior Lelio de Souza sold $543K of AFYA

Junior Lelio de Souza (Vice President) sold 36,204 shares of Afya Ltd (AFYA) at $15.00 ($0.54M total) on 2026-07-01.

Original reporting
SEC EDGAR · Junior Lelio de Souza
Published Jul 6, 2026, 8:55 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 6, 2026, 9:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$AFYA
Neutral
medium confidence
Mentioned
$AFYA
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AFYANeutralLow
01

Why it matters

The disclosed sale is a new, primary-source datapoint about insider activity, but it does not reveal new company performance, guidance, or legal/regulatory developments.

02

Market read

Traders may monitor insider activity for sentiment/flow, but this specific Form 4 does not introduce a fundamental catalyst.

03

What to watch

No follow-on purchases are mentioned, and the article provides no context for why the sale occurred or whether other insiders acted.

Relevance 5/10Novelty 4/10Timing: Filed July 6, 2026 (after-hours) for a July 1 insider sale.

Background

The article is a SEC Form 4 insider transaction disclosure for Afya Ltd by a vice president.

Company-level read

Ticker impact

$AFYANeutralMedium confidence
Context

Afya Ltd VP Junior Lelio de Souza sold 36,204 shares in an open-market transaction for about $543,060 on July 1, 2026.

Expected impact

Low near-term impact; any reaction is likely limited to sentiment/flow rather than a new business catalyst.

Evidence & confidence

The filing is a Form 4 insider transaction (sale) with disclosed size and price, but it does not include new operational, financial, or regulatory information.

Market effects

Sector

Minimal—single insider sale does not provide sector-level signal.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

The absence of a stated 10b5-1 plan could be misread as higher conviction selling, but insider sales are often driven by diversification, taxes, or liquidity needs.

Key entities

  • issuer
    Afya Ltd

    Company whose insider transaction was disclosed on SEC Form 4.

  • insider
    Junior Lelio de Souza

    Vice President who sold 36,204 shares at $15.00/share.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

AFYA insider trading history →

Related articles

AUG 24
$AFYAMed

Afya and Yduqs Confirm Merger Talks of Brazil’s Education Giants

Afya and Yduqs, Brazil's largest medical-education network and education group, confirmed early-stage merger talks on 24 August 2026. Yduqs shares rose 12.1% in São Paulo, while Afya's shares in New York increased 0.77%. The companies' second-quarter financials showed contrasting performances, with Afya in a stronger position. No binding agreements or details have been finalized, and both companies emphasized the preliminary nature of the discussions.

riotimesonline.com2 min
AUG 21
$AFYAMedAI 8/10

Afya (AFYA) Q2 2026 Earnings Call Transcript

Afya (AFYA) reported Q2 2026 revenue of BRL 1.985 billion, up 7% YoY. Adjusted EBITDA rose 3% to BRL 918 million, while net income increased 7% to BRL 463 million. The company faces AI competition in clinical decision tools but is integrating AI into its iClinic platform. Management reaffirmed its full-year EBITDA guidance of BRL 1.7-1.8 billion.

fool.com3 min
AUG 14
$AFYAMed

Afya Q2 Earnings Call Highlights

Afya (NASDAQ:AFYA) reported Q2 earnings call updates. Management said medical course pricing stayed favorable and health science courses grew 13% YoY. Continuing education revenue rose 5% to BRL 144 million; medical practice solutions revenue rose 2% to BRL 85 million. Operating cash flow was BRL 806 million and free cash flow to equity BRL 423 million. Full-year adjusted EBITDA guidance was kept at BRL 1.7-1.8 billion.

finance.yahoo.com4 min
AUG 13
$AFYAMed

Afya Ltd (AFYA): Financial results for Q2 2026

Afya Ltd (AFYA) furnished an SEC Form 6-K — earnings release. Afya Limited Announces Second-Quarter and First-Half 2026 Financial Results R$448 Million Returned to Shareholders 106% of 1H26 FCFE Distributed Through Dividends and Share Repurchases Belo Horizonte, Brazil, August 13, 2026 – Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or th

SEC EDGAR 6-K2 min